Iterative genetic testing identifies SAMHD1 deficiency caused by a homozygous balanced translocation
Details
Publication Year 2026-11-02,Volume 2,Issue #6,Page e20260044
Journal Title
Journal of Human Immunology
Abstract
We present a patient with complex symptoms, including those consistent with familial chilblain lupus (FCL). A de novo likely pathogenic variant in MN1 explains observed microcephaly, sensorineural hearing loss, growth restriction, and mild dysmorphism, but not perniosis with acral autoamputation, small joint arthritis, and immune abnormalities. Transcriptomics revealed a type I IFN signature and strong downregulation of SAMHD1, which is associated with a spectrum of interferonopathies, including FCL. RNA reads from only the first 4 exons of SAMHD1 were detectable, with no coverage of exon 5 onward. Subsequent long-read genome sequencing identified a homozygous, balanced, reciprocal translocation from the SAMHD1 locus on chromosome 20 (q11.23) to chromosome 17 (p11.2). Utilizing an iterative genetic testing approach encompassing exomic, transcriptional, and genomic readouts was invaluable for elucidating the uncommon structural variation carried by this patient. Autozygous balanced, reciprocal translocations are extremely rare, and this appears to be the first case of any inborn error of immunity attributed to this mode of inheritance.
Publisher
RUP
Research Division(s)
Inflammation
PubMed ID
42657394
Open Access at Publisher's Site
https://doi.org/10.70962/jhi.20260044
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-09-07 09:09:45
Last Modified: 2026-09-07 09:09:58
An error has occurred. This application may no longer respond until reloaded. Reload 🗙